Listed

Tectonic Therapeutic, Inc.: Form 10-K for the period ended Dec 31, 2018

Filed with the SEC on Mar 25, 2019 and accepted by EDGAR at Mar 25, 2019, 16:31 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2018-01-01 to 2018-12-31$35.1mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2018-01-01 to 2018-12-31−$46.2mus-gaap:OperatingIncomeLoss
Net income12 months2018-01-01 to 2018-12-31−$46.4mus-gaap:NetIncomeLoss
Diluted EPS12 months2018-01-01 to 2018-12-31−$3.62us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2018-01-01 to 2018-12-31−$37.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2018-01-01 to 2018-12-31$1.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2018-12-31$126.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-12-31$130.0mus-gaap:AssetsCurrent
Total assetsAt period end2018-12-31$133.5mus-gaap:Assets
Current liabilitiesAt period end2018-12-31$10.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-12-31$11.3mus-gaap:Liabilities
Shareholders' equityAt period end2018-12-31$122.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-19-085321. Last ingested by Listed: Nov 5, 2026, 19:21 ET. Listed shows no prices and gives no investment advice.